Yiling Health Science & Technology

Yiling Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceuticals based on the 'Collateral Disease Theory.' The company is most widely recognized for its blockbuster respiratory product, Lianhua Qingwen, which gained international prominence during the COVID-19 pandemic. Beyond TCM, Yiling has expanded into chemical drugs and biologics, focusing on therapeutic areas such as cardiovascular health, oncology, and metabolic diseases. The company operates a vertically integrated business model encompassing research, development, and large-scale GMP manufacturing. Yiling Health Science & Technology specifically focuses on the health supplement and wellness segment of the parent company's portfolio.